Covalent Inhibitors Targeting Mycobacterial Enzymes: Current Status, Challenges and Future Perspectives
Pharmaceuticals · 30.04.2026 · 19 (5) · 707
DOI: 10.3390/ph19050707 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 30.04.2026. Verfasst von Mariana Luiza Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Synthesis of Medicinal Molecules (LaSMMed), Department of Chemistry, State University of Londrina, Rodovia Celso Garcia Cid (PR-445), …. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Milan, CNPq.
Abstract (Originalsprache)
This review offers a critical and comprehensive overview of the most promising covalent inhibitors against traditional and emerging enzymatic targets of Mycobacterium tuberculosis (Mtb). Nearly three decades after the World Health Organisation’s (WHO) declaration of tuberculosis (TB) as a global health emergency, Mtb continues to claim millions of lives, remaining among the leading causes of death worldwide. In recent years, several efforts have been devoted to shortening and improving treatment outcomes and to overcoming increasing drug resistance. The aim of our work is to provide a perspective on recent progress in the field of covalent inhibitors of mycobacterial enzymes, highlighting the current landscape and outlining future directions for safer and more effective strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory for Synthesis of Medicinal Molecules (LaSMMed), Department of Chemistry, State University of Londrina, Rodovia Celso Garcia Cid (PR-445), Londrina 86057-970, Brazil.
- Department of Pharmaceutical Sciences, University of Milan, Via Luigi Mangiagalli 25, 20133 Milano, Italy.
ORCID-Profile: Mariana Luiza Silva, Matteo Mori, Stefania Villa, Andrea Tresoldi, Fiorella Meneghetti, Marcelle de Lima Ferreira Bispo
Förderung
- University of Milan
- CNPq
Zitieren
APA
Silva, M. L., Mori, M., Villa, S., Tresoldi, A., Meneghetti, F., & Bispo, M. L. F. (2026). Covalent Inhibitors Targeting Mycobacterial Enzymes: Current Status, Challenges and Future Perspectives. Pharmaceuticals, 19(5), 707. https://doi.org/10.3390/ph19050707
Vancouver
Silva ML, Mori M, Villa S, Tresoldi A, Meneghetti F, Bispo MLF. Covalent Inhibitors Targeting Mycobacterial Enzymes: Current Status, Challenges and Future Perspectives. Pharmaceuticals. 2026;19(5):707. doi:10.3390/ph19050707
BibTeX
@article{Silva2026,
author = {Silva, Mariana Luiza and Mori, Matteo and Villa, Stefania and Tresoldi, Andrea and Meneghetti, Fiorella and Bispo, Marcelle de Lima Ferreira},
title = {Covalent Inhibitors Targeting Mycobacterial Enzymes: Current Status, Challenges and Future Perspectives},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {5},
pages = {707},
doi = {10.3390/ph19050707}
}
EUVIMED